The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Csl Behring Llc

  • Csl Behring Llc

  • View government funding actions
  • King Of Prussia, PA 194061310
  • Phone: 610-878-4000
  • Estimated Number of Employees: 4,500
  • Estimated Annual Receipts: $2,177,193
  • Business Start Date: 1995
  • Contact Person: John Bunn
  • Contact Phone: 610-878-4000
  • Contact Email: John.Bunn@cslbehring.com
  • Business Structure:
  • Corporate Entity (Not Tax Exempt)
  • Business Type:
  • Foreign Owned and Located
  • For Profit Organization
  • Industries Served: Pharmaceutical Preparation Manufacturing
  • Product Areas: DRUGS AND BIOLOGICALS

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $9,379 - Tuesday the 24th of April 2012
    Veterans Affairs Department
    250-NETWORK CONTRACT OFFICE 10
    ALBUMINAR
  • $9,329 - Friday the 27th of July 2012
    Veterans Affairs Department
    262-NETWORK CONTRACT OFFICE 22
    MEDICAL SUPPLIES 1 ALBUMIN 25% 100ML VIAL
  • $8,437 - Friday the 27th of July 2012
    Veterans Affairs Department
    262-NETWORK CONTRACT OFFICE 22
    PHARMACY SUPPLIES, ALUMIN BOTTLES
  • $8,414 - Tuesday the 26th of June 2012
    Veterans Affairs Department
    636-NEBRASKA WESTERN-IOWA
    MONONINE
  • $8,398 - Friday the 6th of April 2012
    Veterans Affairs Department
    539-CINCINNATI
    MEDICATION
  • $8,398 - Wednesday the 30th of May 2012
    Veterans Affairs Department
    539-CINCINNATI
    MEDICATION
  • $8,274 - Tuesday the 10th of January 2012
    Veterans Affairs Department
    255-NETWORK CONTRACT OFFICE 15
    PRIVIGEN/ALBUMIN
  • $81,892 - Friday the 6th of April 2012
    Veterans Affairs Department
    644-PHOENIX
    EMERGENCY DRUG ORDER (PRIVIGEN)
  • $80,881 - Friday the 27th of July 2012
    Veterans Affairs Department
    626-NASHVILLE
    GLOBULIN: PRIVIGEN (10 GRAM, 40 VIALS&20 GRAM, 60 VIALS)
  • $8,088 - Friday the 17th of February 2012
    Veterans Affairs Department
    623-MUSKOGEE
    PRIVIGEN 10% IMMUNE GLOVULIN INJECTIONS

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.